Atezolizumab + Bevacizumab clinical trials

Fecal Microbiota Transfer in Liver Cancer to Overcome Resistance to Atezolizumab/Bevacizumab (FLORA)

This study looks at combining a treatment called faecal microbiota transplant (FMT) with standard immunotherapy (Atezolizumab/Bevacizumab) for advanced liver cancer. We want to see if FMT can help the immunotherapy work better and if it's safe.